Degron Therapeutics
Develops molecular glue degrader medicines targeting previously undruggable proteins
$40MSeries A+
Role not disclosedLC
LAPAM CAPITAL
Activity from announced rounds
Activity in this selectionsofina-64f2677b
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $40M 1 disclosed · full round size, not this investor’s share